Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)

被引:0
作者
Rezaie, Ali [1 ]
Heimanson, Zeev [2 ]
Israel, Robert J. [2 ]
McCallum, Richard [3 ]
Pimentel, Mark [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Salix Pharmaceut, Bridgewater, NJ USA
[3] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
468
引用
收藏
页码:S269 / S269
页数:1
相关论文
共 50 条
[21]   Rifaximin for improving abdominal pain and bloating symptoms in patients with irritable bowel syndrome with diarrhea (IBS-D) using modified definitions of pain response [J].
Lacy, B. ;
Heimanson, Z. ;
Pimente, M. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
[22]   Infection-Related Safety Profile of Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [J].
Chey, William D. ;
Lembo, Anthony J. ;
Wolf, Ray A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 :S750-S751
[23]   Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment [J].
Pimentel, Mark ;
Lembo, Anthony J. ;
Wolf, Ray .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S240-S240
[24]   Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [J].
Lembo, Anthony J. ;
Rao, Satish ;
Wolf, Ray ;
Pimentel, Mark .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S253-S253
[25]   RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT Mark [J].
Pimentel, Mark ;
Schoenfeld, Philip S. ;
Heimanson, Zeev ;
Cash, Brooks D. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 :S332-S332
[26]   RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT [J].
Pimentel, Mark ;
Schoenfeld, Phillip ;
Heimanson, Zeev ;
Cash, Brooks D. .
GASTROENTEROLOGY, 2018, 154 (06) :S499-S500
[27]   Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial [J].
Wang, Zhaoqin ;
Xu, Manwen ;
Shi, Zheng ;
Bao, Chunhui ;
Liu, Huirong ;
Zhou, Cili ;
Yan, Yilu ;
Wang, Chunye ;
Li, Guona ;
Zhang, Wei ;
Gao, Anqi ;
Wu, Huangan .
JOURNAL OF ETHNOPHARMACOLOGY, 2022, 289
[28]   Intestinal Spirochetosis in an Immunocompetent Patient Carrying a Diagnosis of Irritable Bowel Syndrome With Diarrhea (IBS-D) [J].
Kamionkowski, Sara ;
Issak, Abdulfatah ;
Jacobs, Jaclyn ;
Zhang, Claire ;
Waghray, Nisheet .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 :S949-S949
[29]   Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D) [J].
Smalley, Walter ;
Falck-Ytter, Corinna ;
Carrasco-Labra, Alonso ;
Wani, Sachin ;
Lytvyn, Lyubov ;
Falck-Ytter, Yngve .
GASTROENTEROLOGY, 2019, 157 (03) :858-858
[30]   Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials [J].
Pimentel, Mark ;
Cash, Brooks D. ;
Wolf, Ray ;
Lembo, Anthony J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S253-S254